|

TriClip Japan Post-Approval Study

RECRUITINGSponsored by Abbott Medical Devices
Actively Recruiting
SponsorAbbott Medical Devices
Started2026-03-02
Est. completion2027-02-28
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07509658

Summary

The goal of this observational post approval study is to confirm the safety and efficacy of the TriClip System when used in routine clinical practice in the Japanese population and to fulfill post-market requirements following commercial approval in Japan.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Subjects are eligible to receive the TriClip System per the current approved indications for use (IFU)
* Subjects provide written informed consent prior to conducting any investigation-specific procedures not considered standard of care.

Exclusion Criteria:

* There are no exclusion criteria
* Please note: It is not recommended that subjects enrolled in the study participate in any other therapeutic clinical study.

Conditions2

Heart DiseaseTricuspid Regurgitation

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.